documents: FDA-2014-D-1814-0061

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2014-D-1814-0061 FDA FDA-2014-D-1814 Reference 30 Clostridium perfringens in apheresis platelets an unusual contaminant underscores the importance of clinical vigilance for septic transfusion reactions re Bacterial Detection Testing by Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion; Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2016-03-16T04:00:00Z 2016 3     2016-03-16T17:41:54Z   0 0 0900006481ec38da

Links from other tables